Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples